Advisors Management Group Inc Humanigen, Inc Transaction History

Advisors Management Group Inc

  • $423 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 03, 2023
BUY
$0.09 - $0.2 $2,250 - $5,000
25,000 Added 25.0%
125,000 $15,000
Q3 2022

Oct 21, 2022
BUY
$0.15 - $3.02 $15,000 - $302,000
100,000 New
100,000 $18,000

Others Institutions Holding HGEN

# of Institutions
4
Shares Held
558K
Call Options Held
0
Put Options Held
0
View Full List

About HUMANIGEN, INC

HGEN Quotes by TradingView
  • Ticker HGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,661,000
  • Description
  • Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called ?cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with...
More about HGEN
Track This Portfolio

Track Advisors Management Group Inc Portfolio

Follow Advisors Management Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Management Group Inc , based on Form 13F filings with the SEC.

News

Stay updated on Advisors Management Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email